Results 221 to 230 of about 1,472,132 (249)
Some of the next articles are maybe not open access.

Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma

Clinical Rheumatology, 2022
Xingyu Zhu   +10 more
semanticscholar   +1 more source

An extended high‐frequency ultrasound protocol for assessing and quantifying of inflammation and fibrosis in localized scleroderma

Skin research and technology, 2019
Clinical characteristics of the lesions are used to identify activity and damage in localized scleroderma (LoS). For high‐frequency ultrasound (HF‐US), the features of active lesions were described.
I. Ranosz-Janicka   +3 more
semanticscholar   +1 more source

Prevalence and Incidence of Localized Scleroderma: A Qualitative Systematic Review

Journal of Cutaneous Medicine and Surgery, 2022
Farhana Mahmood   +7 more
semanticscholar   +1 more source

Localized scleroderma

Clinics in Dermatology, 1994
I, Ghersetich   +4 more
openaire   +2 more sources

Localized scleroderma/morphea

International Journal of Dermatology, 2002
Virendra N, Sehgal   +5 more
openaire   +2 more sources

Morphea (Localized Scleroderma)

2016
Morphea, also called localized scleroderma, is a sclerosing skin disorder that resembles scleroderma (systemic sclerosis) in terms of cutaneous histopathological features, but differs demographically and clinically. Hallmark clinical and serological features of scleroderma (sclerodactyly, Raynaud’s phenomenon, internal organ involvement, and ...
Noelle M. Teske, Heidi T. Jacobe
openaire   +1 more source

Morphea (Localized Scleroderma)

The Journal of Pediatrics, 2007
Lisa, Weibel   +2 more
openaire   +2 more sources

[Localized scleroderma (morphea)].

Presse medicale (Paris, France : 1983), 2007
DEFINITION AND FREQUENCY: Localized scleroderma, also known as morphea, is a sclerotic condition limited to the skin. The specific clinical entity depends on the extent, linear disposition and depth of the lesions. Morphea is ten times more prevalent than systemic sclerosis, and its prognosis is generally good: superficial forms resolve within 3 years ...
Waafa, Bono, Nicolas, Dupin
openaire   +1 more source

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

Journal of the European Academy of Dermatology and Venereology
R. Knobler   +42 more
semanticscholar   +1 more source

Morphea (Localized Scleroderma)

2015
Morphea is a fibrosing disorder of the skin without systemic involvement. It can be clinically classified in different forms: circumscribed, linear, generalized, pansclerotic and mixed forms. The pathogenesis is not completely understood. An underlying predisposition and environmental factors are required to develop the disease. No causal treatment for
openaire   +1 more source

Home - About - Disclaimer - Privacy